Open Label, Multicentre Extension Study of Protocol 42603ATT3002 to Evaluate Safety of Prolonged Release OROS Methlyphenidate in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Condition(s):Attention Deficit Disorder With HyperactivityLast Updated:April 21, 2014Completed